Online – April 2017
This guideline addresses four areas related to the treatment of muscle-invasive bladder cancer that has not metastasized. It first discusses initial patient evaluation and counseling and then offers recommendations on treatment. The therapies considered included neoadjuvant chemotherapy, radical cystectomy, pelvic lymphadectomy and bladder preserving approaches. The guideline also looks at patient surveillance, follow-up and survivorship and the role of variant histology for management of urothelial carcinoma.
Read the executive summary
ResourcesMuscle Invasive Bladder Cancer Algorithum
Author SocietyAmerican Society for Radiation OncologyAmerican Urological AssociationAmerican Society of Clinical OncologySociety of Urologic Oncology
ASTRO guidelines present scientific, health, and safety information and may reflect scientific or medical opinion. They are available to ASTRO members and the public for educational and informational purposes only. Commercial use of any content in this guideline without the prior written consent of ASTRO is strictly prohibited.